Research Paper Volume 16, Issue 7 pp 6212—6228
A retrospective study on the effect of Chinese patent medicine combined with conventional treatment on the survival outcomes of 313 patients with stage II–III NSCLC
Figure 5. The survival analysis of patients who received HSOS for different durations (less than 3 months vs. more than 3 months).